USANA Health Sciences, Inc. - 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended April 3, 2010. USANA Health Sciences, Inc. develops and manufactures nutritional and personal care products sold internationally through a network marketing system. The company operates in two primary geographic regions: North America and Asia Pacific. As of the period end, the company reported approximately 204,000 active Associates and 65,000 active Preferred Customers.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $119.1 million | $97.3 million |
| Gross Profit | $96.1 million (80.7% margin) | $77.5 million (79.6% margin) |
| Net Earnings | $9.6 million | $6.6 million |
| Diluted EPS | $0.62 | $0.43 |
| Cash and Equivalents | $21.5 million | $9.7 million |
| Operating Cash Flow | $15.1 million | ($1.3 million) |
| Debt (Line of Credit) | $0 | $7.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 22.4% year-over-year. Approximately $8.6 million of this increase was attributed to favorable currency exchange rate fluctuations. On a local currency basis, growth was driven by a 10.9% increase in active Associates.
- Profitability: Net earnings rose 45.1% to $9.6 million, driven by improved gross margins and lower selling, general, and administrative (SG&A) expenses relative to sales.
- Expense Management: Associate incentives increased to 45.4% of net sales (from 43.1% in Q1 2009) due to higher Matching Bonus payouts and currency impacts. SG&A expenses decreased as a percentage of sales to 23.1% (from 26.0%) due to leverage on higher sales volumes.
- Liquidity: The company paid off its $7.0 million line of credit in April 2010. Operating cash flow turned significantly positive ($15.1 million) compared to a net use of cash in the prior year, which was impacted by an arbitration award and IRS settlement.
- Geographic Performance: Asia Pacific sales grew 41.5% year-over-year, led by a 95.7% increase in active Associates in Hong Kong. North America sales grew 8.3%, despite a slight decline in active Associates, due to increased spending per customer.
Outlook, Risks, and Management Commentary
- Strategic Initiatives: Management plans to implement strategies in the second quarter to manage Associate incentives relative to net sales, specifically targeting the Matching Bonus portion of the compensation plan. International policy changes are also planned to align the compensation plan with net sales growth, which may temporarily slow growth in certain markets.
- Capital Resources: The company maintains a $40 million credit facility with Bank of America, which is currently unused. The company is in compliance with debt covenants requiring adjusted EBITDA of at least $50 million.
- Risks: Key risks include the ability to attract and retain Associates, dependence on the network marketing model, regulatory scrutiny of network marketing practices, and foreign currency fluctuations. The company notes that a strengthening U.S. dollar negatively impacts reported sales and earnings.
- Legal Proceedings: A purported class action lawsuit (Chirco vs. USANA et. al) remains pending in Nevada. The company believes the claims are without merit and intends to defend vigorously.
Investor Verification Checklist
- Verify the sustainability of the 10.9% growth in active Associates, particularly the 95.7% surge in Hong Kong.
- Monitor the impact of upcoming compensation plan changes on Associate incentives as a percentage of net sales.
- Assess the exposure to foreign currency fluctuations, given that 68.4% of sales are generated outside the U.S.
- Review the status of the pending Chirco class action litigation for potential financial contingencies.
- Confirm the company's ability to maintain adjusted EBITDA above the $50 million covenant threshold.